- Home
- GOSS vs IHRT Comparison
GOSS vs IHRT Comparison
Compare GOSS & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | IHRT |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.7M | 552.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOSS | IHRT |
|---|---|---|
| Price | $0.42 | $3.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $8.83 | $4.33 |
| AVG Volume (30 Days) | ★ 16.9M | 502.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $114,701,000.00 | N/A |
| Revenue This Year | N/A | $1.98 |
| Revenue Next Year | $6.41 | $5.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $0.95 |
| 52 Week High | $3.87 | $5.44 |
Technical Indicators
Market Signals| Indicator | GOSS | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 13.82 | 45.80 |
| Support Level | N/A | $3.01 |
| Resistance Level | $1.31 | $3.51 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 1.65 | 53.17 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.